Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Cancer Medicine|November 12, 2020
Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcomaDaniela Meier, Andreas Lodberg, Ana Gvozdenovic, et al.BMC Cancer|September 27, 2018
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinomaDennis Lindenblatt, Nastassja Terraneo, Giovanni Pellegrini, et al.Diabetes Research and Clinical Practice|May 15, 2007
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetesCristina Bianchi, Giuseppe Penno, Francesca Pancani, et al.Clinical Chemistry|January 30, 2007
Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patientsLaura Pucci, Stefano Triscornia, Daniela Lucchesi, et al.EJNMMI Research|February 11, 2016
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folateStephanie Haller, Giovanni Pellegrini, Christiaan Vermeulen, et al.Nanomaterials (Basel, Switzerland)|October 27, 2022
Surface-Enhanced Raman Spectroscopy Chips Based on Silver Coated Gold NanostarsMiriam Parmigiani, Benedetta Albini, Giovanni Pellegrini, et al.Thyroid : Official Journal of the American Thyroid Association|November 25, 2020
Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid TumorsLoredana Lorusso, Cristina Romei, Paolo Piaggi, et al.Scientific Reports|July 20, 2018
A micron-scale surface topography design reducing cell adhesion to implanted materialsFrancesco Robotti, Simone Bottan, Federica Fraschetti, et al.Scientific Reports|September 10, 2017
The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restrictionThomas Knöpfel, Eva M Pastor-Arroyo, Udo Schnitzbauer, et al.Toxicology|July 9, 2013
Intraperitoneal administration of high doses of polyethylene glycol (PEG) causes hepatic subcapsular necrosis and low-grade peritonitis with a rise in hepatic biomarkersGiovanni Pellegrini, Phil J Starkey Lewis, Luke Palmer, et al.Pageof 9